Posts by Galit Alter, PhD
-
Monoclonal Antibodies for COVID-19 Need to Be "Tuned" to the Immune System
Caroline Atyeo and Galit Alter, PhD, of the Ragon Institute, and colleagues caution that an investigational monoclonal antibody against SARS-CoV-2 had both immune-protective and immunopathological effects, suggesting the need for strategic engineering of Fc receptors.
-
Distinct Immune Responses Develop in Hospitalized Patients with COVID-19
Galit Alter, PhD, of the Ragon Institute of Massachusetts General Hospital, MIT and Harvard, and colleagues have found distinct patterns of humoral immune responses to SARS-CoV-2 that track with whether the patient survived.
-
Medical Grand Rounds: The Quest for a COVID-19 Vaccine
On November 5, 2020, the Department of Medicine held a virtual Grand Rounds on COVID-19. Bruce Walker, MD, and Galit Alter, PhD, from the Ragon Institute, spoke with the local Boston medical community about the quest for a COVID-19 vaccine.
-
MGH Research Scholars Respond to COVID-19
This video highlights how the MGH Research Scholars rapidly mobilized to address key medical and scientific challenges posed by COVID-19.
-
Early Immune Responses Predict Outcome of Severe COVID-19
Five early immune response markers, considered together, correctly classified plasma samples as belonging to survivors or non-survivors of severe COVID-19.
-
Medical Grand Rounds: How Diagnostic Tests for COVID-19 Got Us into, and Will Lead Us Out of, the Pandemic
On April 30, 2020, the eighth lecture in the Medical Grand Rounds' COVID-19 series focused on the role of diagnostic testing during the COVID-19 pandemic in leading us back to our normal lives.
-
"Inflammatory Tsunami" Causes Severe Disease After Infection with the SARS-CoV-2 Coronavirus
Infection with SARS-CoV-2, the coronavirus that's causing the pandemic of COVID-19, can cause a remarkably strong cytokine storm that leads to acute respiratory distress syndrome even, in people who initially presented with mild to moderate symptoms.
Biography
Dr. Galit Alter is a Professor of Medicine at the Ragon Institute of Mass General, MIT and Harvard. Her researched is focused on the development of systems biology tools to define the correlates of immunity against infectious diseases that ravage the globe. Her work points to unexpected mechanisms of protection against HIV, malaria and tuberculosis, has led to the development of novel diagnostics to monitor chronic infections/diseases and now promises to accelerate the development of novel classes of therapeutics able to deploy the activity of the innate immune system in a specific and controlled manner.
